A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

The unprecedented coronavirus disease 2019 (COVID-19) epidemic has created a worldwide public health emergency, and there is an urgent need to develop an effective vaccine to control this severe infectious disease. Here, we find that a single vaccination with a replication-defective human type 5 ade...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shipo, Zhong, Gongxun, Zhang, Jun, Shuai, Lei, Zhang, Zhe, Wen, Zhiyuan, Wang, Busen, Zhao, Zhenghao, Song, Xiaohong, Chen, Yi, Liu, Renqiang, Fu, Ling, Zhang, Jinlong, Guo, Qiang, Wang, Chong, Yang, Yilong, Fang, Ting, Lv, Peng, Wang, Jinliang, Xu, Junjie, Li, Jianmin, Yu, Changming, Hou, Lihua, Bu, Zhigao, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427994/
https://www.ncbi.nlm.nih.gov/pubmed/32796842
http://dx.doi.org/10.1038/s41467-020-17972-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427994/
https://www.ncbi.nlm.nih.gov/pubmed/32796842
http://dx.doi.org/10.1038/s41467-020-17972-1

Ejemplares similares